Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Global superbug fight 'needs $5b a year'
antibiotics
Rising antibiotic resistance is triggering the emergence of superbugs that can cause life-threatening infections, such as MRSA or drug-resistant tuberculosis.
Scientists call for a co-ordinated response to drug resistant infections
 
A global fund of $5billion a year is needed to tackle drug-resistant infections, according to predictions by a team of international scientists.

Rising antibiotic resistance is triggering the emergence of superbugs that can cause life-threatening infections, such as MRSA or drug-resistant tuberculosis.

Writing in the journal Science, researchers called for a World Bank Trust Fund to co-ordinate the response to this growing public health crisis.

The annual sum of $5b will be required to develop global systems to monitor resistance and establish a framework to address the threat, they added. It could also speed up the development of new vaccines, diagnostics and treatments, in addition to regulatory processes to ensure medicines are used appropriately.

The group also recommended introducing targets to cut the number of resistant infections over the next five years and putting global limits on antibiotic use. In particular, they believe the use of antibiotics to promote the growth of farmed animals should be phased out across the globe.

In addition, improved access to clean water, sanitation and public health infrastructure, will reduce the spread of disease and the overall need for antibiotics, scientists argued.

Professor Mark Woolhouse from the University of Edinburgh, who took part in the research, added: "Drug resistance knows no borders, as we have seen with the spread of superbugs around the world.

"It is crucial that nations come together with appropriate financing and governance to tackle this challenge together."

Become a member or log in to add this story to your CPD history

RCVS Knowledge appoints Veterinary Evidence editor-in-chief

News Story 1
 RCVS Knowledge has welcomed Professor Peter Cockcroft as editor-in-chief for Veterinary Evidence.

A world-renowned expert in evidence-based veterinary medicine, Prof Cockcroft will lead the strategic development and editorial quality of the open-access journal. He was previously in the role from 2017-2020.

Katie Mantell, CEO of RCVS Knowledge, said: "We are excited about the extensive knowledge of evidence-based veterinary medicine and clinical veterinary research that Peter brings, and we look forward to working with him over this next phase of the journal's development." 

Click here for more...
News Shorts
Defra to host bluetongue webinar for vets

The Department for Environment, Food and Rural Affairs (Defra) will be hosting a webinar for veterinary professional on bluetongue on Thursday, 25 April 2024.

Topics covered will include the transmission cycle, pathology and pathogenesis, clinical signs (including signs seen in recent BTV-3 cases in the Netherlands), and control and prevention.

The session, which will take place from 6pm to 7.30pm, is part of Defra's 'Plan, Prevent and Protect' webinar series, which are hosted by policy officials, epidemiologists and veterinary professionals from Defra and the Animal and Plant Health Agency. The bluetongue session will also feature insights from experts from The Pirbright Institute.

Those attending will have the opportunity to ask questions. Places on the webinar can be booked online.